Health & Welfare
Pellet-based oral vaccine holds promise for VNN protection
An oral vaccine delivered via fish feed to defend against Viral Nervous Necrosis could be ready for market soon if everything goes according to plan for startup VakSea.
Innovation & Investment
Global Aquaculture Innovation Award finalist: VakSea
An orally administered vaccine product holds great promise for aquaculture, and Maryland-based startup VakSea is on the cusp of providing one. Sensing a major opportunity, the company’s focus has pivoted to shrimp.
